CME Group Hits Fresh One-Year High as It Expands Uranium and Globex Offerings

CME Group closed at $315.87 on November 11, 2026, marking a fresh one-year high. The close moved past its prior annual peak from March 2 by 0.08%. The stock had previously dropped close to $219 toward the middle of the year before rebounding. Partner exchange Nasdaq fell 0.31% on the same day.

The milestone follows an announcement on November 11, 2026, detailing plans to launch a physically backed uranium futures contract. The derivative aims to address increasing demand for nuclear power and enhance price discovery. CME is reportedly nearing a finalized storage agreement with ConverDyn, while Solstice would oversee inventories at the sole commercial-scale U.S. uranium conversion facility in Illinois. Uranium prices have tripled over the past six years.

The exchange operator is also preparing an operational update for CME Globex scheduled for Sunday, November 15, with trading starting Monday, November 16. The enhancement introduces implied trading for calendar and butterfly spreads in select short-term interest-rate futures, along with exchange-defined implied calendar spreads for E-mini equity index contracts such as the S&P 500 Equal Weight, Russell 1000, and Russell 2000. Regulators are also reviewing planned Nikkei Basis Trade at Cash Open contracts set to trade starting November 18, while Treasury Link spreads remain targeted for the first quarter of 2027.

Third-party evaluations highlight mixed financial metrics. GuruFocus reported a 3.77% dividend yield alongside a high payout ratio of 93% and a three-year dividend growth rate of -16.2%. The firm calculated a GF Value of $285.43, placing the recent stock price roughly 10% above its estimate. Over the past 12 months, company insiders sold $36.3 million in shares while buying $0.7 million. Among 19 tracked investment gurus, 10 expanded their holdings and 5 reduced them.

In an investor letter, Cooper Investors Global Equities Fund reported that CME Group was its top contributor for the third quarter of 2026. The fund noted that CME achieved 16% volume growth during the quarter, supported by easing worries regarding competition from perpetual futures.